DK460386A - 2-oxo-1-(((substitueret sulfonyl)-amino)-carbonyl)-azetidiner eller farmaceutisk acceptable salte deraf samt deres fremstilling - Google Patents
2-oxo-1-(((substitueret sulfonyl)-amino)-carbonyl)-azetidiner eller farmaceutisk acceptable salte deraf samt deres fremstilling Download PDFInfo
- Publication number
- DK460386A DK460386A DK460386A DK460386A DK460386A DK 460386 A DK460386 A DK 460386A DK 460386 A DK460386 A DK 460386A DK 460386 A DK460386 A DK 460386A DK 460386 A DK460386 A DK 460386A
- Authority
- DK
- Denmark
- Prior art keywords
- azetidines
- oxo
- carbonyl
- amino
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78047985A | 1985-09-26 | 1985-09-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK460386D0 DK460386D0 (da) | 1986-09-26 |
| DK460386A true DK460386A (da) | 1987-03-27 |
Family
ID=25119699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK460386A DK460386A (da) | 1985-09-26 | 1986-09-26 | 2-oxo-1-(((substitueret sulfonyl)-amino)-carbonyl)-azetidiner eller farmaceutisk acceptable salte deraf samt deres fremstilling |
Country Status (31)
| Country | Link |
|---|---|
| JP (1) | JPS6284082A (zh) |
| KR (1) | KR900001013B1 (zh) |
| CN (1) | CN86106980A (zh) |
| AT (1) | ATA257986A (zh) |
| AU (1) | AU600912B2 (zh) |
| BE (1) | BE905502A (zh) |
| CA (1) | CA1308719C (zh) |
| CH (1) | CH670828A5 (zh) |
| DD (1) | DD250121A5 (zh) |
| DE (1) | DE3632876A1 (zh) |
| DK (1) | DK460386A (zh) |
| EG (1) | EG18314A (zh) |
| ES (1) | ES2001995A6 (zh) |
| FI (1) | FI863890A (zh) |
| FR (1) | FR2587700B1 (zh) |
| GB (1) | GB2181130B (zh) |
| GR (1) | GR862449B (zh) |
| HU (1) | HU198044B (zh) |
| IE (1) | IE59686B1 (zh) |
| IL (1) | IL80160A (zh) |
| IT (1) | IT1214533B (zh) |
| LU (1) | LU86611A1 (zh) |
| NL (1) | NL8602446A (zh) |
| NO (1) | NO863837L (zh) |
| NZ (1) | NZ217704A (zh) |
| PH (1) | PH23315A (zh) |
| PL (1) | PL151546B1 (zh) |
| PT (1) | PT83440B (zh) |
| SE (1) | SE8604089L (zh) |
| YU (1) | YU46177B (zh) |
| ZA (1) | ZA867373B (zh) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01502660A (ja) * | 1986-05-23 | 1989-09-14 | ジ・アップジョン・カンパニー | Ｎ―１置換スルホニルアミノカルボニル、ｃ―４置換モノバクタム類 |
| AU602067B2 (en) * | 1987-02-11 | 1990-09-27 | Upjohn Company, The | Novel n-1 substituted beta-lactams as antibiotics |
| US5006650A (en) * | 1987-02-11 | 1991-04-09 | The Upjohn Company | Novel N-1 substituted beta-lactams as antibiotics |
| EP0357604A1 (en) * | 1987-02-27 | 1990-03-14 | The Upjohn Company | Antibiotic beta-lactams containing a pyridone carboxylic acid or acid derivative |
| CA1317298C (en) * | 1987-03-03 | 1993-05-04 | Upjohn Company (The) | Antibiotic sulfonylaminocarbonyl activated .beta.-lactams |
| US4762922A (en) * | 1987-07-01 | 1988-08-09 | Squibb Corporation | 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines |
| US4772693A (en) * | 1987-07-01 | 1988-09-20 | E. R. Squibb & Sons, Inc. | 2-oxo-1-((Substituted sulfonyl)amino)-carbonyl)azetidines |
| US5015737A (en) * | 1987-07-22 | 1991-05-14 | The Upjohn Company | Therapeutically useful beta-lactams |
| AU2125188A (en) * | 1987-07-22 | 1989-02-13 | Upjohn Company, The | Therapeutically useful beta-lactams |
| US4777252A (en) * | 1987-08-13 | 1988-10-11 | E. R. Squibb & Sons, Inc. | 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines |
| US4889930A (en) * | 1987-12-21 | 1989-12-26 | E. R. Squibb & Sons, Inc. | Process for making 2-oxo-1-((substituted sulfonyl)amino)carbonzyl)azetidines and intermediates used therein |
| US4871841A (en) * | 1987-12-23 | 1989-10-03 | E. R. Squibb & Sons, Inc. | 2-Oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines |
| JPH01290674A (ja) * | 1988-04-04 | 1989-11-22 | E R Squibb & Sons Inc | アゼチジニル誘導体 |
| US4959470A (en) * | 1988-08-17 | 1990-09-25 | E. R. Squibb & Sons, Inc. | 2-oxo-[[(substituted sulfonyl)-amino]carbonyl]-azetidines |
| DE69325083T2 (de) * | 1992-12-23 | 1999-10-28 | Novartis Ag | Imidazol-Derivate und ihre Verwendung als agrochemische Mittel |
| EP0671654B1 (en) * | 1994-03-11 | 1997-09-10 | Agfa-Gevaert N.V. | Photographic material containing a new type of hydrazide |
| WO2005063704A1 (ja) * | 2003-12-25 | 2005-07-14 | Ono Pharmaceutical Co., Ltd. | アゼチジン環化合物およびその医薬 |
| GB201111704D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Novel compounds |
| GB201111705D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Compounds and their use |
| JO3115B1 (ar) | 2011-08-22 | 2017-09-20 | Takeda Pharmaceuticals Co | مركبات بيريدازينون واستخدامها كمثبطات daao |
| AU2012337781B2 (en) | 2011-11-15 | 2017-07-06 | Takeda Pharmaceutical Company Limited | Dihydroxy aromatic heterocyclic compound |
| GB201222711D0 (en) | 2012-12-17 | 2013-01-30 | Takeda Pharmaceutical | Novel compounds |
| CN106986820B (zh) * | 2017-02-24 | 2019-05-21 | 浙江工商大学 | 多功能的羟基吡啶酮衍生物及其水合物的制备法和用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ199981A (en) * | 1981-04-09 | 1985-08-16 | Squibb & Sons Inc | 2-oxo-1-(((substituted sulphonyl)amino)carbonyl)azetidines |
| CA1272726C (en) * | 1982-01-04 | 1990-08-14 | 2-oxo-1-(aminocarbonylaminosulfonyl- aminocarbonyl)azetidines | |
| US4939253A (en) * | 1982-08-04 | 1990-07-03 | E. R. Squibb & Sons, Inc. | 2-oxoazetidin-1-yloxy acetic acids and analogs |
| US4801705A (en) * | 1986-06-23 | 1989-01-31 | E. R. Squibb & Sons, Inc. | 2-oxo-1-(((substituted sulfonyl)amino)-carbonyl)azetidines |
-
1986
- 1986-09-25 EG EG603/86A patent/EG18314A/xx active
- 1986-09-26 PL PL1986261575A patent/PL151546B1/pl unknown
- 1986-09-26 LU LU86611A patent/LU86611A1/fr unknown
- 1986-09-26 HU HU864124A patent/HU198044B/hu not_active IP Right Cessation
- 1986-09-26 AT AT0257986A patent/ATA257986A/de not_active Application Discontinuation
- 1986-09-26 FR FR8613466A patent/FR2587700B1/fr not_active Expired
- 1986-09-26 GB GB8623151A patent/GB2181130B/en not_active Expired
- 1986-09-26 FI FI863890A patent/FI863890A/fi not_active Application Discontinuation
- 1986-09-26 DE DE19863632876 patent/DE3632876A1/de not_active Ceased
- 1986-09-26 NL NL8602446A patent/NL8602446A/nl active Search and Examination
- 1986-09-26 PH PH34303A patent/PH23315A/en unknown
- 1986-09-26 KR KR1019860008067A patent/KR900001013B1/ko not_active IP Right Cessation
- 1986-09-26 IL IL80160A patent/IL80160A/xx not_active IP Right Cessation
- 1986-09-26 DK DK460386A patent/DK460386A/da not_active Application Discontinuation
- 1986-09-26 ZA ZA867373A patent/ZA867373B/xx unknown
- 1986-09-26 DD DD86295013A patent/DD250121A5/de not_active IP Right Cessation
- 1986-09-26 IE IE254786A patent/IE59686B1/en not_active IP Right Cessation
- 1986-09-26 AU AU63156/86A patent/AU600912B2/en not_active Ceased
- 1986-09-26 CN CN198686106980A patent/CN86106980A/zh active Pending
- 1986-09-26 CH CH3860/86A patent/CH670828A5/fr not_active IP Right Cessation
- 1986-09-26 JP JP61229474A patent/JPS6284082A/ja active Pending
- 1986-09-26 SE SE8604089A patent/SE8604089L/xx not_active Application Discontinuation
- 1986-09-26 ES ES8602204A patent/ES2001995A6/es not_active Expired
- 1986-09-26 PT PT83440A patent/PT83440B/pt unknown
- 1986-09-26 NO NO863837A patent/NO863837L/no unknown
- 1986-09-26 YU YU165986A patent/YU46177B/sh unknown
- 1986-09-26 BE BE0/217217A patent/BE905502A/fr not_active IP Right Cessation
- 1986-09-26 CA CA000519170A patent/CA1308719C/en not_active Expired - Lifetime
- 1986-09-26 GR GR862449A patent/GR862449B/el unknown
- 1986-09-26 IT IT8621834A patent/IT1214533B/it active
-
1988
- 1988-09-26 NZ NZ217704A patent/NZ217704A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK460386D0 (da) | 2-oxo-1-(((substitueret sulfonyl)-amino)-carbonyl)-azetidiner eller farmaceutisk acceptable salte deraf samt deres fremstilling | |
| DK208787D0 (da) | Quinolinderivater og farmaceutisk acceptable estere deraf, deres farmaceutisk acceptable salte samt fremstilling og anvendelse deraf | |
| DK61887A (da) | Substituerede 5-amino-4-hydroxy-valerylderivater og salte deraf samt deres fremstilling og anvendelse | |
| DK516583A (da) | Tricycliske aminosyrer eller salte deraf, deres fremstilling og anvendelse samt mellemprodukter og disses fremstilling | |
| DK519189D0 (da) | Spiro-isoquinolin-pyrrolidin-tetroner eller farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse | |
| DK298984D0 (da) | Tetrahydropyridazinoner eller syreadditionssalte deraf, deres fremstilling og anvendelse som laegemidler samt mellemprodukter og disses fremstilling | |
| DK266486A (da) | Quinoloncarboxylsyreestere eller farmaceutisk anvendelige hydratereller syreadditionssalte deraf, deres fremstilling og anvendelse | |
| DK539087A (da) | 4,5-dihydro- og 4,5,6,7-tetrahydro-pyrazolooe1,5-aaapyrimidiner, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler | |
| DK291485A (da) | Usymmetriske aliphatiske thioethere og salte deraf samt deres fremstilling og anvendelse | |
| NO892269D0 (no) | Ikke-hyperglykosylerte hepatitt b-virus-proteiner samt ekspresjons-"kassetter" og fremgangsmaate for fremstilling avproteinene. | |
| DK467588D0 (da) | Anilinophenylthiourinstoffer, -isothiourinstoffer og -carbodiimider samt deres fremstilling og anvendelse | |
| DK179786D0 (da) | (-)-1beta-ethyl-1alfa-hydroxylmethyl-1,2,3,4,6,7,12,12balfa-octa-hydroindolo(2,3-a)quinolizin og syreadditionssalte deraf, deres fremstilling og anvendelse som farmaceutika | |
| DK541085A (da) | Substituerede benzamider og salte deraf samt deres fremstilling og anvendelse | |
| DK154586A (da) | Alkanoylanilider eller salte deraf, deres fremstilling og anvendelse som insekticider og arachmicider | |
| DK460287D0 (da) | Substituerede thiourinstoffer, isothiourinstoffer og carbodiimider samt deres fremstilling og anvendelse | |
| DK343486A (da) | Dihydroquinolinon-derivater, deres fremstilling og anvendelse som laegemidler samt ved fremstillingen anvendte mellemprodukter og disses fremstilling | |
| DK555486A (da) | Cephalosporiner eller salte deraf, deres fremstilling og anvendelse som laegemidler | |
| DK167785D0 (da) | Substituerede 1-aminoalkylamino-4-aryloxypiperidiner eller farmaceutisk acceptable salte deraf, deres fremstilling og mellemprodukter hertil samt deres anvendelse som analgetika | |
| DK886D0 (da) | 1,3-disubstituerede tetrahydropyridiner og salte deraf samt deres fremstilling og anvendelse | |
| DK355587D0 (da) | 2-penem-3-carboxylsyre-forbindelser og salte deraf samt deres fremstilling og anvendelse | |
| DK238786A (da) | Bicycliske aminosyrer eller fysiologiske uskadelige salte deraf, deres fremstilling og anvendelse som laegemidler samt mellemprodukter til fremstillingen og disses fremstilling | |
| DK264688A (da) | Annelerede (thio)hydantoiner, fremgangsmaade til deres fremstilling samt deres anvendelse | |
| DK404386D0 (da) | Spergualinbeslaegtede forbindelser eller fysiologisk acceptable salte deraf, deres fremstilling og anvendelse | |
| DK192588A (da) | Pyrrolaldehyder eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse | |
| DK287487A (da) | 4-phenyl-4-oxo-2-butensyrederivater, deres fremstilling samt laegemidler med indhold deraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |